Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy.

PURPOSE To establish guidelines for delineating the clinical target volume for pelvic nodal irradiation by mapping the location of lymph nodes in relation to the pelvic anatomy. METHODS AND MATERIALS Twenty patients with gynecologic malignancies underwent magnetic resonance imaging with administration of iron oxide particles. All visible lymph nodes were outlined. Five clinical target volumes were generated for each patient using modified margins of 3, 5, 7, 10, and 15 mm around the iliac vessels. The nodal contours were then overlaid and individual nodes analyzed for coverage. The volume of normal tissue within each clinical target volume and planning target volume was also measured to aid selection of the margin that could provide maximal nodal, but minimal normal tissue, coverage. RESULTS In total, 1216 nodal contours were evaluated. The nodal coverage was 56%, 76%, 88%, 94%, and 99% using vessel margins of 3, 5, 7, 10, and 15 mm, respectively. The mean volume of bowel within the planning target volume was 146.9 cm3 with a 7-mm margin, 190 cm3 with a 10-mm margin, and 266 cm3 with a 15-mm margin. Minor modification to the 7-mm margin ensured 99% coverage of the pelvic nodes. CONCLUSION Blood vessels with a modified 7-mm margin offer a good surrogate target for pelvic lymph nodes. By making appropriate adjustments, coverage of specific nodal groups may be increased and the volume of normal tissue irradiated decreased. On the basis of these findings, recommended guidelines for outlining pelvic nodes have been produced.

[1]  J. Buatti,et al.  Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer? , 2003, International journal of radiation oncology, biology, physics.

[2]  P. Koper,et al.  The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial , 2002 .

[3]  John C Roeske,et al.  Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. , 2003, International journal of radiation oncology, biology, physics.

[4]  M R Segal,et al.  Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. , 1997, JAMA.

[5]  B. Corn,et al.  Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. , 1996, International journal of radiation oncology, biology, physics.

[6]  D. Koh,et al.  Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. , 2004, Radiology.

[7]  B. Marincek,et al.  USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results , 2004, European Radiology.

[8]  J Williamson,et al.  Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. , 1999, International journal of radiation oncology, biology, physics.

[9]  D P Dearnaley,et al.  Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[10]  N. Sakuragi,et al.  Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy , 1999, Cancer.

[11]  S. Way,et al.  OBSERVATIONS ON LYMPH NODE INVOLVEMENT IN CARCINOMA OF THE CERVIX , 1953 .

[12]  John C Roeske,et al.  Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.

[13]  E. Henriksen The lymphatic spread of carcinoma of the cervix and of the body of the uterus; a study of 420 necropsies. , 1949, American journal of obstetrics and gynecology.

[14]  J. Tierney,et al.  A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  J. Cain,et al.  Gynecologic radiotherapy fields defined by intraoperative measurements. , 1990, Gynecologic oncology.

[16]  D Low,et al.  Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. , 2001, International journal of radiation oncology, biology, physics.

[17]  K. Eichler,et al.  Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. , 2002, Radiology.

[18]  A. Norman,et al.  MR evaluation of normal retroperitoneal and pelvic lymph nodes. , 2002, Clinical radiology.

[19]  G. Marchal,et al.  Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) – results of a phase-III multicenter clinical trial , 2002, European Radiology.

[20]  M. Harisinghani,et al.  Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  G. Scambia,et al.  Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. , 1996, Gynecologic oncology.

[22]  Chun-Chieh Wang,et al.  Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[23]  A. Norman,et al.  Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. , 1995, Radiology.

[24]  J. Mcivor Changes in lymph node size induced by lymphography. , 1980, Clinical radiology.

[25]  K. Chao,et al.  Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.

[26]  J. Roeske,et al.  Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. , 2000, International journal of radiation oncology, biology, physics.

[27]  S. Pendlebury,et al.  Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer. , 1993, International journal of radiation oncology, biology, physics.

[28]  H. Pannu,et al.  MR imaging of mediastinal lymph nodes: Evaluation using a superparamagnetic contrast agent , 2000, Journal of magnetic resonance imaging : JMRI.

[29]  Patrick M M Bossuyt,et al.  Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. , 2003, Gynecologic oncology.

[30]  N. deSouza,et al.  Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. , 2001, AJR. American journal of roentgenology.

[31]  S. Kalnicki,et al.  Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. , 2003, Gynecologic oncology.